Autopsy report · NCT02932488

Cerebral Pharmacodynamic Effects of 5-HT1B Receptor Stimulation

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Pilot study with sumatriptan found no significant changes in the primary outcome parameter (change in CBF)”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 2 years 9 months before it stopped.
17 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Gitte Moos Knudsen
Sponsor type: University, hospital or other
Conditions: Healthy Volunteers
Interventions: Sumatriptan
Participants: 17
Sites: 1
Countries: Denmark

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.